Efecto de la asociación de bloqueadores beta e inhibidores de la enzima de conversión en la supervivencia al año tras un infarto agudo de miocardio. Resultados del registro PRIAMHO II
- 1 April 2006
- journal article
- Published by Elsevier in Revista Espanola de Cardiologia
- Vol. 59 (4) , 313-320
- https://doi.org/10.1157/13087059
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Documento de Consenso de Expertos sobre el uso de inhibidores de la enzima de conversión de la angiotensina en la enfermedad cardiovascularRevista Espanola de Cardiologia, 2004
- ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive SummaryCirculation, 2004
- Management of acute myocardial infarction in patients presenting with ST-segment elevationEuropean Heart Journal, 2003
- ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary articleJournal of the American College of Cardiology, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP)The American Journal of Cardiology, 2001
- ACC/AHA guidelines for the management of patients with unstable angina and non–st-segment elevation myocardial infarction: A report of the american college of cardiology/ american heart association task force on practice guidelines (committee on the management of patients with unstable angina)Published by Elsevier ,2000
- Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patientsThe Lancet, 2000
- beta Blockade after myocardial infarction: systematic review and meta regression analysisBMJ, 1999
- Adjunctive Drug Therapy of Acute Myocardial Infarction — Evidence from Clinical TrialsNew England Journal of Medicine, 1996